Literature DB >> 32818226

Cellular and molecular profiling of T-cell subsets at the onset of human acute GVHD.

Eleonora Latis1,2, David Michonneau3,4, Claire Leloup1, Hugo Varet5, Régis Peffault de Latour3,4, Elisabetta Bianchi1, Gérard Socié3,4, Lars Rogge1.   

Abstract

The cellular and molecular processes involved in acute graft-versus-host disease (aGVHD) development early after allogeneic hematopoietic cell transplantation (HCT) in humans remain largely unknown. We have performed multiparameter immunophenotyping and molecular profiling of CD4+ and CD8+ T cells in 2 independent cohorts of patients undergoing HCT, as well as in their HLA-identical sibling donors. Cellular profiling using spectral flow cytometry showed an incomplete reconstitution of the T-cell compartment in recipients without aGVHD early after transplantation, as well as a shift toward an effector memory phenotype, paralleled by depletion of the naive T-cell pool. Molecular profiling of T-cell populations in donors vs recipients without aGVHD revealed increased pathway activity of >40 gene modules in recipients. These pathways were associated in particular with T-cell activation, adhesion, migration, and effector functions. Cellular profiles from recipients developing aGVHD displayed an enrichment of cells with a T memory stem cell-like phenotype compared with recipients without aGVHD. Comparison of gene profiles from these recipients revealed that transforming growth factor-β (TGF-β) signaling was most significantly downregulated, whereas the pathway activity of NF-κB-associated transcription factors and signaling pathways were increased, at aGVHD onset. This study suggests that the integration of cellular and molecular profiles provides new insights into the development of aGVHD in humans.
© 2020 by The American Society of Hematology.

Entities:  

Mesh:

Year:  2020        PMID: 32818226      PMCID: PMC7448585          DOI: 10.1182/bloodadvances.2019001032

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  55 in total

Review 1.  Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.

Authors:  Ruth Seggewiss; Hermann Einsele
Journal:  Blood       Date:  2010-03-09       Impact factor: 22.113

Review 2.  Chemokines and chemokine receptors: positioning cells for host defense and immunity.

Authors:  Jason W Griffith; Caroline L Sokol; Andrew D Luster
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

3.  Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification.

Authors:  Christella E Widjaja; Jocelyn G Olvera; Patrick J Metz; Anthony T Phan; Jeffrey N Savas; Gerjan de Bruin; Yves Leestemaker; Celia R Berkers; Annemieke de Jong; Bogdan I Florea; Kathleen Fisch; Justine Lopez; Stephanie H Kim; Daniel A Garcia; Stephen Searles; Jack D Bui; Aaron N Chang; John R Yates; Ananda W Goldrath; Hermen S Overkleeft; Huib Ovaa; John T Chang
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

4.  Transcription Factor IRF4 Promotes CD8+ T Cell Exhaustion and Limits the Development of Memory-like T Cells during Chronic Infection.

Authors:  Kevin Man; Sarah S Gabriel; Yang Liao; Renee Gloury; Simon Preston; Darren C Henstridge; Marc Pellegrini; Dietmar Zehn; Friederike Berberich-Siebelt; Mark A Febbraio; Wei Shi; Axel Kallies
Journal:  Immunity       Date:  2017-12-12       Impact factor: 31.745

Review 5.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

Review 6.  Homeostatic cytokines in immune reconstitution and graft-versus-host disease.

Authors:  Stéphanie Thiant; Moutuaata M Moutuou; Dominique Leboeuf; Martin Guimond
Journal:  Cytokine       Date:  2016-02-01       Impact factor: 3.861

7.  Human naive CD8 T cells down-regulate expression of the WNT pathway transcription factors lymphoid enhancer binding factor 1 and transcription factor 7 (T cell factor-1) following antigen encounter in vitro and in vivo.

Authors:  Tim Willinger; Tom Freeman; Mark Herbert; Hitoshi Hasegawa; Andrew J McMichael; Margaret F C Callan
Journal:  J Immunol       Date:  2006-02-01       Impact factor: 5.422

8.  Prediction of graft-versus-host disease in humans by donor gene-expression profiling.

Authors:  Chantal Baron; Roland Somogyi; Larry D Greller; Vincent Rineau; Peter Wilkinson; Carolyn R Cho; Mark J Cameron; David J Kelvin; Pierre Chagnon; Denis-Claude Roy; Lambert Busque; Rafick-Pierre Sékaly; Claude Perreault
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

9.  Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model.

Authors:  Aude Burlion; Simon Brunel; Nicolas Y Petit; Daniel Olive; Gilles Marodon
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

10.  NFAT primes the human RORC locus for RORγt expression in CD4+ T cells.

Authors:  Hanane Yahia-Cherbal; Magda Rybczynska; Domenica Lovecchio; Tharshana Stephen; Chloé Lescale; Katarzyna Placek; Jérome Larghero; Lars Rogge; Elisabetta Bianchi
Journal:  Nat Commun       Date:  2019-10-16       Impact factor: 14.919

View more
  3 in total

1.  Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.

Authors:  Shannon R McCurdy; Vedran Radojcic; Hua-Ling Tsai; Ante Vulic; Elizabeth Thompson; Sanja Ivcevic; Christopher G Kanakry; Jonathan D Powell; Brian Lohman; Djamilatou Adom; Sophie Paczesny; Kenneth R Cooke; Richard J Jones; Ravi Varadhan; Heather J Symons; Leo Luznik
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

Review 2.  Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.

Authors:  Gérard Socié; Leslie S Kean; Robert Zeiser; Bruce R Blazar
Journal:  J Clin Invest       Date:  2021-06-15       Impact factor: 19.456

Review 3.  GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models.

Authors:  Nicholas J Hess; Matthew E Brown; Christian M Capitini
Journal:  Front Immunol       Date:  2021-07-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.